Clinical Trial Update: Maternal Immunization With MenAfriVac™ [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for maternal immunization with MenAfriVac targeting meningitis/meningococcal disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis
• Meningococcal Disease

Drugs mentioned

• MenAfriVac (Meningococcal A conjugate vaccine)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Meningitis, Meningococcal | Phase 3 | Status: UNKNOWN